Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 2
2003 2
2004 3
2005 4
2006 3
2007 1
2008 1
2010 1
2011 2
2012 2
2014 1
2015 2
2018 1
2022 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

26 results

Results by year

Filters applied: . Clear all
Page 1
Therapeutic Immunization against Glioblastoma.
Schijns VEJC, Pretto C, Strik AM, Gloudemans-Rijkers R, Deviller L, Pierre D, Chung J, Dandekar M, Carrillo JA, Kong XT, Fu BD, Hsu FPK, Hofman FM, Chen TC, Zidovetzki R, Bota DA, Stathopoulos A. Schijns VEJC, et al. Int J Mol Sci. 2018 Aug 27;19(9):2540. doi: 10.3390/ijms19092540. Int J Mol Sci. 2018. PMID: 30150597 Free PMC article. Review.
Oil-based emulsion vaccine adjuvants.
Schijns VEJC, Strioga M, Ascarateil S. Schijns VEJC, et al. Curr Protoc Immunol. 2014 Aug 1;106:2.18.1-2.18.7. doi: 10.1002/0471142735.im0218s106. Curr Protoc Immunol. 2014. PMID: 25081910 Review.
Trends in vaccine adjuvants.
Schijns VE, Lavelle EC. Schijns VE, et al. Expert Rev Vaccines. 2011 Apr;10(4):539-50. doi: 10.1586/erv.11.21. Expert Rev Vaccines. 2011. PMID: 21506650 Review.
Immunology of vaccine adjuvants.
Ribeiro CM, Schijns VE. Ribeiro CM, et al. Among authors: schijns ve. Methods Mol Biol. 2010;626:1-14. doi: 10.1007/978-1-60761-585-9_1. Methods Mol Biol. 2010. PMID: 20099117
A Prospective, Cohort Study of SITOIGANAP to Treat Glioblastoma When Given in Combination With Granulocyte-Macrophage Colony-Stimulating Factor/Cyclophosphamide/Bevacizumab/Nivolumab or Granulocyte-Macrophage Colony-Stimulating Factor/Cyclophosphamide/Bevacizumab/Pembrolizumab in Patients Who Failed Prior Treatment With Surgical Resection, Radiation, and Temozolomide.
Bota DA, Taylor TH, Lomeli N, Kong XT, Fu BD, Schönthal AH, Singer S, Blumenthal DT, Senecal FM, Linardou H, Rokas E, Antoniou DG, Schijns VEJC, Chen TC, Elliot J, Stathopoulos A. Bota DA, et al. Among authors: schijns vejc. Front Oncol. 2022 Jun 28;12:934638. doi: 10.3389/fonc.2022.934638. eCollection 2022. Front Oncol. 2022. PMID: 35837107 Free PMC article.
Structure- and oil type-based efficacy of emulsion adjuvants.
Jansen T, Hofmans MP, Theelen MJ, Manders F, Schijns VE. Jansen T, et al. Among authors: schijns ve. Vaccine. 2006 Jun 29;24(26):5400-5. doi: 10.1016/j.vaccine.2006.03.074. Epub 2006 Apr 17. Vaccine. 2006. PMID: 16675072
26 results